🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,071 results for “tablet” Clear

  1. Fimasartan/Atorvastatin Combination Tablet

    Yung NA

    Hypertension

    phase 1 small molecule completed

    1 trial

  2. Finasteride 5 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  3. Finlepsin 200 retard, 200 mg, tabletki o przedłużonym uwalnianiu, Orungal, 100 mg, kapsułki, Gemfibrozilo STADA 600 mg comprimidos recubiertos con película EFG, Neurotop retard 300, 300 mg, tabletki o przedłużonym uwalnianiu

    Minoryx Therapeutics S.L.

    Adrenoleukodystrophy

    phase 1 small molecule active

    1 trial

  4. Freethiadine tablets(part I)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  5. GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets

    Alfasigma S.p.A.

    juvenile idiopathic arthritis

    phase 1 small molecule active

    1 trial

  6. GLPG1205 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  7. GLPG1690 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  8. GLPG1972 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  9. GLPG3970 film-coated tablet

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  10. GLPG3970 film-coated tablet

    Lakefront Biotherapeutics NV

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  11. GS-5245 tablets 175 mg, GS-5245 tablets 350 mg

    Gilead Sciences Pty Limited

    Renal Impairment

    phase 1 small molecule active

    1 trial

  12. GSBR-1290 (Capsule/Tablet)

    Structure Therapeutics

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  13. GST-HG121 tablets

    The First People's Hospital of Lianyungang

    Pharmacokinetics

    phase 1 small molecule active

    1 trial

  14. GST-HG121 tablets

    Jian Li

    Pharmacokinetics

    phase 1 small molecule active

    1 trial

  15. Glimepiride 4 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  16. Glucophage® XR 750 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  17. Glyburide/Metformin 5 mg/500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  18. Granisetron hydrochloride 1 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  19. HEC113995 PA•H2O tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  20. HEC113995PA•H2O tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  21. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 small molecule completed

    1 trial

  22. HEC83518 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  23. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  24. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources